Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3928/19382359-20201116-02

http://scihub22266oqcxt.onion/10.3928/19382359-20201116-02
suck pdf from google scholar
33290568!ä!33290568

suck abstract from ncbi

pmid33290568      Pediatr+Ann 2020 ; 49 (12): e509-e515
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Vaccine Development: From Laboratory to Policy #MMPMID33290568
  • Park HS; Samuels EL; Bocchini JA Jr
  • Pediatr Ann 2020[Dec]; 49 (12): e509-e515 PMID33290568show ga
  • Vaccines are one of the greatest public health achievements, protecting children and adults against numerous infectious diseases; however, the complex, rigorous process of vaccine development is unknown to many. A candidate vaccine undergoes extensive evaluation of safety and efficacy to meet licensure requirements before recommendations for use become policy. This time-consuming process involves an intricate collaboration among academia, public and private organizations, and federal agencies to ensure that safety is prioritized in every step. Vaccine safety continues to be monitored after licensure through a robust system. Yet, vaccine hesitancy remains a major challenge, especially now with the coronavirus disease 2019 (COVID-19) pandemic and concerns about the speed with which candidate vaccines are being developed. This article reviews the vaccine development process and the systems in place to ensure safety and effectiveness. A better understanding of these topics is necessary to address concerns and improve public acceptance of all vaccines, particularly COVID-19 vaccines. [Pediatr Ann. 2020;49(12):e509-e515.].
  • |*Drug Approval[MESH]
  • |Clinical Trials as Topic[MESH]
  • |Humans[MESH]
  • |Licensure[MESH]
  • |Product Surveillance, Postmarketing[MESH]
  • |Safety Management[MESH]
  • |United States[MESH]
  • |United States Food and Drug Administration[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box